Programmed death 1 (PD1)/paradigm of surface-expressed programmed death ligand 1 (PDL1) is a popular pathway target in cancer research and has important therapeutic potential, which can reduce T cell activity through the interaction of PD1 and PDL1 (62–65). Here, CD274 is linked to cancer.